(Q45889434)

English

Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: a potential approach for local delivery of cytokines during vaccination

scientific article published on 7 December 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16376465

Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: a potential approach for local delivery of cytokines during vaccination (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16376465

author name string

Shanmugam Nagarajan

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16376465

Periasamy Selvaraj

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16376465

language of work or name

0 references

publication date

7 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16376465

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16376465

24

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16376465

13

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16376465

2264-2274

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16376465

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Development of therapeutic vaccines by direct modification of cell membranes from surgically removed human tumor tissue with immunostimulatory molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Designer cancer vaccines made easy: protein transfer of immunostimulatory molecules for use in therapeutic tumor vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Cancer vaccine development: protein transfer of membrane-anchored cytokines and immunostimulatory molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Tumor cells transfected with B7-1 and interleukin-12 cDNA induce protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Detection of a soluble form of B7-1 (CD80) in synovial fluid from patients with arthritis using monoclonal antibodies against distinct epitopes of human B7-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Modified cell ELISA to determine the solubilization of cell surface proteins: Applications in GPI-anchored protein purification

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

IL-12 as an adjuvant for cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Gene transfer to liver cancer cells of B7-1 plus interleukin 12 changes immunoeffector mechanisms and suppresses helper T cell type 1 cytokine production induced by interleukin 12 alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Cytokine-secreting tumor cell vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Coordination of chemokine and adhesion systems in intratumoral T cell migration responsible for the induction of tumor regression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Interleukin-12: a cytokine at the interface of inflammation and immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

The diphtheria toxin transmembrane domain as a pH sensitive membrane anchor for human interleukin-2 and murine interleukin-3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.045

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.11.045

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16376465

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16376465

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45889434&oldid=2088696187"